AusCann (ASX:AC8) up more than 65pc after completing testing of hard-shell capsules
- Medicinal cannabis company AusCann Group (AC8) is up more than 65 per cent today after completing manufacturing and testing of its hard-shall capsules
- Once tested, the capsules were found to have met all applicable criteria set out by the Australian Therapeutic Goods Administration (TGA)
- These capsules are a unique presentation for cannabinoid medicines and a clinical evaluation will provide the best dose selection
Click to view full article